Cosmos Health (NASDAQ:COSM) CEO Grigorios Siokas Purchases 353,321 Shares

Cosmos Health Inc. (NASDAQ:COSM) CEO Grigorios Siokas acquired 353,321 shares of the firm’s stock in a transaction dated Tuesday, January 20th. The stock was bought at an average price of $0.50 per share, for a total transaction of $176,660.50. Following the completion of the acquisition, the chief executive officer owned 8,091,795 shares in the company, valued at approximately $4,045,897.50. The trade was a 4.57% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Grigorios Siokas also recently made the following trade(s):

• On Wednesday, January 14th, Grigorios Siokas bought 493,495 shares of Cosmos Health stock. The stock was bought at an average price of $0.45 per share, with a total value of $222,072.75.
• On Monday, January 12th, Grigorios Siokas bought 113,185 shares of Cosmos Health stock. The stock was purchased at an average cost of $0.50 per share, for a total transaction of $56,592.50.
• On Thursday, January 8th, Grigorios Siokas purchased 156,190 shares of Cosmos Health stock. The shares were purchased at an average price of $0.52 per share, for a total transaction of $81,218.80.
• On Wednesday, January 7th, Grigorios Siokas purchased 124,880 shares of Cosmos Health stock. The shares were purchased at an average price of $0.52 per share, with a total value of $64,937.60.
• On Tuesday, January 6th, Grigorios Siokas purchased 133,953 shares of Cosmos Health stock. The shares were purchased at an average price of $0.54 per share, with a total value of $72,334.62.
• On Friday, December 19th, Grigorios Siokas acquired 88,314 shares of Cosmos Health stock. The stock was purchased at an average cost of $0.49 per share, with a total value of $43,273.86.
• On Monday, December 15th, Grigorios Siokas acquired 168,472 shares of Cosmos Health stock. The stock was purchased at an average price of $0.42 per share, for a total transaction of $70,758.24.
• On Friday, November 28th, Grigorios Siokas bought 76,360 shares of Cosmos Health stock. The shares were purchased at an average cost of $0.64 per share, for a total transaction of $48,870.40.
• On Tuesday, November 25th, Grigorios Siokas bought 55,732 shares of Cosmos Health stock. The shares were purchased at an average price of $0.63 per share, with a total value of $35,111.16.
• On Friday, November 21st, Grigorios Siokas bought 56,080 shares of Cosmos Health stock. The stock was purchased at an average cost of $0.68 per share, with a total value of $38,134.40.

Cosmos Health Stock Up 5.0%

Shares of NASDAQ:COSM opened at $0.52 on Thursday. The firm has a market capitalization of $19.46 million, a PE ratio of -0.69 and a beta of 5.37. Cosmos Health Inc. has a 1 year low of $0.28 and a 1 year high of $1.32. The company has a debt-to-equity ratio of 0.25, a current ratio of 0.99 and a quick ratio of 0.84. The firm’s 50-day moving average is $0.54 and its two-hundred day moving average is $0.73.

Cosmos Health (NASDAQ:COSM) last posted its quarterly earnings data on Friday, November 14th. The company reported ($0.17) EPS for the quarter, missing the consensus estimate of ($0.01) by ($0.16). Cosmos Health had a negative net margin of 31.01% and a negative return on equity of 33.19%. The business had revenue of $17.11 million during the quarter, compared to analysts’ expectations of $16.40 million. Analysts predict that Cosmos Health Inc. will post -0.78 EPS for the current year.

Institutional Trading of Cosmos Health

An institutional investor recently raised its position in Cosmos Health stock. Citadel Advisors LLC raised its position in Cosmos Health Inc. (NASDAQ:COSM) by 133.1% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 225,507 shares of the company’s stock after acquiring an additional 128,776 shares during the quarter. Citadel Advisors LLC owned approximately 0.65% of Cosmos Health worth $250,000 as of its most recent SEC filing. Institutional investors and hedge funds own 12.61% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Cosmos Health in a research report on Wednesday, October 8th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Cosmos Health presently has an average rating of “Sell”.

About Cosmos Health

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors.